欧必亭与康泉预防化疗引起恶心呕吐的临床疗效  

The clinical effect of Tropisetron in the prevention of nausea and vomiting induced by anti-cancer drugs

作　　者：王金万[1] 杨林[1] 崔成旭[1] 屈涛[1] 王兴元[1] 李玉升[1] 王佳玉[1] 储大同[1] 

机构地区：[1]中国医学科学院中国协和医科大学肿瘤研究所肿瘤医院内科,北京100021

出　　处：《中华肿瘤杂志》2001年第3期251-253,共3页Chinese Journal of Oncology

摘　　要：目的　观察欧必亭 (Tropisetron)预防化疗所致恶心呕吐的疗效和不良反应 ,并与康泉(Kytril)进行对比研究。方法　采用临床随机自身对照方法 ,将 34例接受联合化疗 (19例含顺铂 )的患者随机分为AB、BA两组 ,均接受两个周期相同方案的化疗。AB组第 1周期用欧必亭 ,第 2周期用康泉 ;BA组第 1周期用康泉 ,第 2周期用欧必亭。结果　化疗第 1天欧必亭组止吐的有效率为97.1% ,中位呕吐次数为 4.5次 ;康泉的有效率为 94.1% ,中位呕吐次数为 3次 ,经统计学处理 ,两组差异无显著性。对迟发性呕吐和副作用也进行了对比 ,欧必亭和康泉差异亦无显著性。结论　欧必亭为预防化疗所致恶心呕吐的有效药物 ,其不良反应轻微。Objective To compare the efficacy and adverse effects of Tropisetron with Kytril in the prevention of nausea and vomiting induced by anti cancer drugs.Methods In a clinical randomized controlled cross over trial, 34 patients (19 among them treated with regimens containing cisplatin) were randomized into A and B group. In group A, Tropisetron was given in the first cycle and Kytril in the second cycle, while in group B Kytril was given in the first and Tropisetron in the second cycle of the same chemotherapy. Results In the Tropisetron treated group, the response rate was 97.1% with 4.5 episodes of vomiting on the first day of chemotherapy, while that in the Kytril treated patients was 94.1% with 3 episodes of vomiting. There was no statistical difference between the 2 groups. Control of delayed emesis and other adverse reactions were comparable in both arms and there was no notable difference between Tropisetron and Kytril.Conclusion Tropisetron is an effective anti emetic drug to prevent nausea and vomiting caused by anti tumor agents, and its adverse reactions are mild.

关 键 词：欧必亭 康泉 恶心/预防和控制 呕吐/预防和控制 

分 类 号：R730.5[医药卫生—肿瘤]